The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Yazar: | Jackson, M |
---|---|
Diğer Yazarlar: | Vallis, K |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2013
|
Konular: |
Benzer Materyaller
-
Selective targeting of homologous recombination deficiency
Yazar:: Zimmer, J
Baskı/Yayın Bilgisi: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Yazar:: Albukhari, A
Baskı/Yayın Bilgisi: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Yazar:: Albukhari, A
Baskı/Yayın Bilgisi: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
Yazar:: Potter, M
Baskı/Yayın Bilgisi: (2014) -
Radiopharmaceutical Validation for Clinical Use
Yazar:: Charles A. Kunos, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)